IP Verse

Intas Pharmaceuticals patent opposition analysis

Get complete Patent Opposition Report for Intas Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Intas Pharmaceuticals

Explore patent oppositions filed by Intas Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3529360	Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein Reduction	NOVARTIS	Jan 16, 2025
EP3270909	Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular Risk	ESPERION THERAPEUTICS	Aug 1, 2024
EP2653162	Methods Of Administering Fluvoxamine Therapy	INTERMUNE	Feb 19, 2021
EP2506850	Methods Of Administering Pirfenidone Therapy	INTERMUNE	Feb 15, 2021
EP3246021	Apixaban Formulations	BRISTOL MYERS SQUIBB IRELAND	Aug 12, 2020
EP3251660	Apixaban Formulations	BRISTOL MYERS SQUIBB IRELAND	Jul 15, 2020
EP3257500	Apixaban Formulations	BRISTOL MYERS SQUIBB IRELAND	Jul 15, 2020
EP3017811	Apixaban Formulations	BRISTOL MYERS SQUIBB	Sep 4, 2019
EP3023095	Direct Compression Formulation And Process	NOVARTIS	Feb 15, 2019
EP2956129	Pharmaceutical Compositions Containing Dexketoprofen And Tramadol	LABORATORIOS MENARINI	Jan 18, 2019

Latest patents of Intas Pharmaceuticals opposed by its competitors

Explore Intas Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3833335	Aug 31, 2022	Pharmaceutical Composition Comprising Hmg-Coa Reductase Inhibitors And Fenofibrate	2
EP2978426	Nov 13, 2019	Stable Tigecycline Composition	2
EP2917192	Mar 20, 2019	Process For The Preparation Of Cabazitaxel And Its Intermediates	1

Top competitors of Intas Pharmaceuticals

MUNDIPHARMA

NOVARTIS

BRISTOL MYERS SQUIBB IRELAND